Risk Factors for Neurodegeneration

Risk factors for neurodegeneration include trauma, lifestyle, and allelic variants of disease-associated genes with incomplete penetrance. Here is the latest research.

January 9, 2021

Infectious keratitis: an update on epidemiology, causative microorganisms, risk factors, and antimicrobial resistance

Darren Shu Jeng TingHarminder S Dua
January 12, 2021
Open Access

Does Diet Have a Role in the Treatment of Alzheimer's Disease?

Frontiers in Aging Neuroscience
Mitchell Thelen, Holly M Brown-Borg
January 23, 2021

Global pandemics interconnected - obesity, impaired metabolic health and COVID-19.

Nature Reviews. Endocrinology
Norbert StefanMatthias B Schulze
January 11, 2021
Open Access

Could COVID-19 anosmia and olfactory dysfunction trigger an increased risk of future dementia in patients with ApoE4?

Medical Hypotheses
Ciro ManzoAlberto Castagna
January 24, 2021
Open Access

Cellular senescence in the aging retina and developments of senotherapies for age-related macular degeneration.

Journal of Neuroinflammation
Keng Siang LeeJian Liu
January 11, 2021

Is SGSH heterozygosity a risk factor for early-onset neurodegenerative disease?

Journal of Inherited Metabolic Disease
Meghan L DouglassKim M Hemsley
January 21, 2021
Open Access

Cognitive and Neuropsychiatric Profiles in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinson's Disease.

Journal of Personalized Medicine
Francesca AssognaClelia Pellicano
January 12, 2021
Open Access

Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study

The Lancet. Respiratory Medicine
Brenda T PunCOVID-19 Intensive Care International Study Group
January 15, 2021

A comprehensive review on the neuropathophysiology of selenium.

The Science of the Total Environment
Mohammad NaderiRaymond W M Kwong
January 9, 2021
Open Access

Trends of multimorbidity in 15 European countries: a population-based study in community-dwelling adults aged 50 and over

BMC Public Health
Dyego L B SouzaJavier Jerez-Roig
January 16, 2021
Open Access

Multiple genetic pathways regulating lifespan extension are neuroprotective in a G2019S LRRK2 nematode model of Parkinson's disease.

Neurobiology of Disease
Megan M SenchukDarren J Moore
January 21, 2021
Open Access

The Neuromelanin Paradox and Its Dual Role in Oxidative Stress and Neurodegeneration.

Alexandra Moreno-GarcíaOlga Calero
January 23, 2021

Impact of Genetic Risk Factors for Alzheimer's Disease on Brain Glucose Metabolism.

Molecular Neurobiology
Sukhee ChoJinsoo Seo
January 15, 2021

Clear cell degeneration associated with endometriosis of abdominal wall after cesarean section: A case report and systematic review of literature

The Journal of Obstetrics and Gynaecology Research
Federico FerrariFranco Odicino

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved